Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer.
about
Polyamines and cancer: implications for chemotherapy and chemopreventionDrug repurposing and human parasitic protozoan diseasesSpermine synthase deficiency leads to deafness and a profound sensitivity to alpha-difluoromethylornithine.Positive feedback by a potassium-selective inward rectifier enhances tuning in vertebrate hair cells.Difluoromethylornithine: the proof is in the polyamines.Growth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5'-methylthioadenosine phosphorylase.In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells.Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells.Recent advances in the development of polyamine analogues as antitumor agents.Targeting polyamine metabolism for cancer therapy and prevention.Ornithine decarboxylase, mitogen-activated protein kinase and matrix metalloproteinase-2 expressions in human colon tumorsLongitudinal assessment of air conduction audiograms in a phase III clinical trial of difluoromethylornithine and sulindac for prevention of sporadic colorectal adenomas.Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism.
P2860
Q26864516-009A505C-77A2-44E9-A972-EE50F49B86DBQ26999453-A679CDD7-E3B2-4934-BF59-05332B57AD03Q30484125-9954A5C8-7E64-45B6-A988-06141D224637Q30538302-7D530DD9-2375-4BD8-A284-5C8D4CD8738AQ33859016-F4EA202D-6E6E-467D-819D-2C02B4F7BA64Q34575673-C06B66C5-130D-4114-8ACC-FCD23ABEB8ACQ36790732-55227664-7DB2-4F12-8D66-990E2E3CB76BQ37023820-1F8D6BEA-034B-4CD2-A811-A632D0E95D05Q37522449-3F9EC656-B94F-444A-B881-D6F631F30BD8Q38966691-D543C787-57A2-454F-8FBD-6A6F9FEF9547Q42144367-F87619CC-2BF4-41B3-979E-D92D27DBD09EQ43105749-B482024E-578E-4BC7-9DD8-1A23B5F75104Q48154027-740C2DAF-EC90-4A90-BB3E-B1DDC10CAD45
P2860
Phase II trials of alpha-difluoromethylornithine, an inhibitor of polyamine synthesis, in advanced small cell lung cancer and colon cancer.
description
1986 nî lūn-bûn
@nan
1986 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
name
Phase II trials of alpha-diflu ...... lung cancer and colon cancer.
@ast
Phase II trials of alpha-diflu ...... lung cancer and colon cancer.
@en
type
label
Phase II trials of alpha-diflu ...... lung cancer and colon cancer.
@ast
Phase II trials of alpha-diflu ...... lung cancer and colon cancer.
@en
prefLabel
Phase II trials of alpha-diflu ...... lung cancer and colon cancer.
@ast
Phase II trials of alpha-diflu ...... lung cancer and colon cancer.
@en
P2093
P1476
Phase II trials of alpha-diflu ...... l lung cancer and colon cancer
@en
P2093
P304
P577
1986-07-01T00:00:00Z